Zirabev
Analogs of Zirabev
Find cheaper analogs and generic equivalents for Zirabev.
Active Ingredient: bevacizumab
Product Overview
About Zirabev
Zirabev is a prescription medicine that should be supervised by a doctor who has experience in the use of cancer medicines.
What it is used for
There is no information available on what Zirabev is used for.
How it is used
Zirabev is given by infusion (drip) into a vein. The first infusion of Zirabev should last 90 minutes, but subsequent infusions may be given more quickly if the first infusion does not cause troublesome side effects. The dose, which is given every 2 or 3 weeks, depends on the patient’s weight, the type of cancer being treated and what other cancer medicines are being used. Treatment is continued until the cancer is no longer controlled. The doctor may decide to interrupt or stop treatment if the patient develops certain side effects.
How it works
The active substance in Zirabev, bevacizumab, is a monoclonal antibody (a type of protein) that has been designed to attach to vascular endothelial growth factor (VEGF), a protein that circulates in the blood and encourages the growth of new blood vessels. By attaching to VEGF, Zirabev stops its effect. As a result, the cancer cannot develop its own blood supply and cancer cells are starved of oxygen and nutrients, helping to slow down the growth of tumours.
Active substance: bevacizumab
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
